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Edited by Irmgard SinningAbstract The V2 vasopressin receptor, a member of the rhodop-
sin subfamily of GPCRs, mediates arginine vasopressin control of
water reabsorption in the kidney by activating Gs. Requirement
of the third intracellular loop of the V2R for Gs activation was
identiﬁed by introducing V2R segments into the Gq coupled
V1aR [Liu, J. and Wess, J. (1996) J. Biol. Chem. 271, 8772–8778];
the same approach recognized glutamate 231 and glutamine
225 at the amino terminus of loop 3i as being needed for signal
transduction. Site-directed mutagenesis of the V2R conﬁrmed
their observations. Recently, we found that a positively charged
amino acid at codon 268 is essential for V2R expression, although
a double-mutant bearing lysine at position 231 and glutamic acid
at position 268 was expressed at higher levels than the wild type
V2R and displayed unchanged ligand-binding aﬃnity. Ligand-in-
duced internalization and phosphorylation of the double-mutant
receptor was indistinguishable from that observed with the wild
type protein but signaling activity was greatly diminished. The
data suggested these two amino acids might interact with each
other and might play a role in promoting GDP/GTP exchange.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Comparison of amino acid composition and mutagenesis
have been used to search for GPCR domains involved in G
protein activation. The heterogeneity of GPCRs is far greater
than that of G proteins, and as a consequence, less is known
about the regions of the receptor that promote GDP/GTP ex-
change beyond the fact that intracellular loops one, two or
three are crucial for G protein activation [3,8,12,22,27].
A large number of V2R single amino acid mutations have
been identiﬁed in individuals aﬀected with nephrogenic diabe-
tes insipidus, a disease characterized by the inability of the
kidney to produce concentrated urine in response to arginine
vasopressin (AVP) [5]. In most cases, the mutations reduce
cell surface receptors to levels unable to mediate hormonal
response in vivo [20]. To reduce this undesirable result of
mutagenesis, investigators have applied a ‘‘gain of function’’
approach to identify signaling domains. Intracellular seg-
ments of receptor subtypes that bind the same ligand, AVP,
but couple to diﬀerent G proteins are exchanged to identify
those that can confer a new coupling activity to the recipient*Corresponding author. Fax: +1 919 541 0500.
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and V2 receptor subtypes that stimulate Gq/11 or Gs, respec-
tively [16]. The exchange between the V1a and V2 receptors
identiﬁed the 3i loop as responsible for Gs activation by the
V2R [10,16]. Exchange of smaller segments identiﬁed glu-
tamic acid 231 at the amino terminus of the 3i loop and
the proximal glutamine 225 as two amino acids required
for Gs activation.
Lysine 268, located at the boundary of the 3i loop and TMVI
(Fig. 1A) was mutagenized in an attempt to eliminate reactive
free amino groups from the receptor. This amino acid had been
previously studied by Martin et al. [18] as a possible site of V2R
ubiquitination; these authors described the K268R mutant
receptor as having similar expression and stimulatory activity
as the wild type. We initiated our studies to identify availability
of sites for chemical reactivity with ﬂuorescent dyes. Depending
on the identity of the amino acid that replaced K268, the impact
of the mutation on receptor abundance was very signiﬁcant (for
alanine) or less pronounced (arginine, glutamic acid) with a
concordant reduction in the ability of these mutant receptors
to stimulate adenylyl cyclase activity. The importance of lysine
268 for V2R folding became apparent when we noticed that
mutation of the three adjacent amino acids had no eﬀect on
receptor expression or coupling. The importance of this amino
acid was undetectable by the ‘‘gain of function’’ approach be-
cause the homologous domain of the V1aR is lysine rich.
As the experiments presented indicate, mutagenesis of the
V2R conﬁrmed the importance of this conserved lysine and re-
vealed some proximity of both stems of the 3i loop as well as
their role in Gs activation.2. Materials and methods
2.1. Materials
Dulbecco-modiﬁed Eagle medium (DMEM), Hanks buﬀered salt
solution, Dulbeccos PBS (D-PBS), Penicillin/Streptomycin, 0.5%
Trypsin/5mM EDTA, Geneticin (G-418), and fetal bovine serum
(FBS) were from GIBCO, Grand Island, NY; cell culture plasticware
was from COSTAR, Cambridge, MA; AVP was from Peninsula Lab-
oratories, Belmont, CA. All other reagents were from Sigma, St. Louis,
MO. [3H] Arginine vasopressin, speciﬁc activity 60–80Ci/mmol; [a-32P]
ATP, speciﬁc activity 3000Ci/mmol, and [3H] cyclic 3 0,5 0-AMP was
from ICN Biochemicals, Irvine, CA.
2.2. Construction of mutant V2 receptors
The amino acid changes detailed in Table 1 were introduced into the
V2R using a PCR based approach [13]. The resulting constructs were
sequenced fully by the dideoxy chain termination method of Sanger
et al. [25]. For expression in eucaryotic cells the cDNAs were cloned
into the expression vector pcDNA3 (Invitrogen, Boston, MA).European Biochemical Societies.
Fig. 1. (A) Alignment of the amino acids of human V2R, rat V1a and bovine opsin and between TM V and TM VI. (B) Frontal view of the
transmembrane domains indicating the location of D136, E231 and K268 in a tertiary structure of the human V2R modeled according to the
alignment between bovine rhodopsin and V2R. The alignment was performed as described in Section 2. Brieﬂy, homologs of each sequence were
gathered using Blast searches [1]. Separate multiple alignments of these two sets of sequences were performed using ClustalW [26]. Subsequently this
pair of alignments was aligned using the proﬁle alignment option of ClustalW. The 1F88.pdb ﬁle of bovine rhodopsin was used to deﬁne the
parameters of the amino acids.
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COS.M6 and HEK 293T cells were grown in DMEM-high glucose,
supplemented with 10% heat-inactivated FBS, penicillin (50 units/ml)
and streptomycin (50 lg/ml).
2.4. Transient expression in cells
COS.M6 or HEK 293 cells, kept below 75% conﬂuence, were plated
at a density of 1.0 or 2.8 · 106 cells per 100 mm dish, respectively, and
transfected the following day by a previously reported modiﬁcation of
the method of Luthman and Magnusson [13,17].
2.5. Phosphorylation of the V2R in intact cells
Transiently or stably transfectedHEK293T cells were plated in 6-well
plates (6–8 · 105 cells/well). After 18 h, the cells were washed, exposed to
MEM phosphate-free medium for 30 min, and then labeled 2 h at 37 C
with 100 lCi/well of [32P]H3PO4. After labeling the cells were exposed to
100 nM AVP for 30 min at 37 C, the plates were chilled, washed twice,
and lysed to isolate the receptor by immunoprecipitation utilizing an
anti V2R polyclonal antibody as previously described [13]. The isolated
proteins were electrophoresed in 10% polyacrylamide gels and visual-
ized by exposing the dried gels to Kodak-X-omat ﬁlm at70 C. Quan-
tiﬁcation of the 32P incorporated into proteins was performed using a
Molecular Dynamics PhosphoImager, (Sunnyvale, CA). The results
are expressed as percent of the phosphorylation detected after treating
the WT V2R with 100 nM AVP for 30 min at 37 C. Data presented
are the mean of three independent experiments ±S.E.M.
2.6. Hormone binding to intact cells
Cells were plated in 12-well plates at a density of 0.5–1.0 · 105 cells/
well. Binding assays were performed the following day as previously
described [13]. Replicate wells were trypsinized and their cell content
determined to normalize the results as binding sites per cell. Binding
experiments were performed at least three times, the data are reported
as mean ±S.E.M.2.7. Adenylyl cyclase activity in cell homogenates
Adenylyl cyclase activity was assayed as previously described [4].
The experiments were performed at least three times. The values for
adenylyl cyclase activity are expressed as the mean ±S.E.M.2.8. cAMP accumulation in intact cells
Transiently transfected HEK 293 cells expressing the WT or the
E231K/K268E V2R were plated in a 24-well plate and each well
was labeled overnight with 2 lCi of [3H] adenine to label the cellular
ATP pools. The next day the cells were washed and exposed for
15 min at 37 C to 1 mM isobutyl-methyl-xanthine in Dulbecco-
PBS/0.1% bovine serum albumin, followed by a 15 min challenge
with 100 nM AVP or the indicated hormones. The reaction was
stopped by the addition of 5% TCA containing 1 mM ATP, 1 mM
cAMP and 10000 cpm of [14C] cAMP to each well. cAMP was iso-
lated by the double column chromatographic method of Salomon
et al. [24]. Recovery of [14C] cAMP counts was used to correct
[3H] cAMP values.2.9. V2R sequestration and recycling
Cells were plated in polylysine-treated 24-well plates at a density of
1.5 · 105 cells/well 24 h after transfection. The following day the cells
were challenged with 100 nM AVP in DMEM high glucose containing
1% BSA and 20 mM HEPES (pH 7.4) for 20 min at 37 C. Plates were
then chilled on crushed ice and the cells washed twice with cold D-PBS,
twice with ice-cold 150 mM NaCl/5 mM acetic acid and ﬁnally three
times with D-PBS. 500 ll of DMEM/BSA/HEPES solution was added
to each well and the cells were returned to 37 C for the indicated time.
The number of receptors on the cell surface was then evaluated by [3H]
AVP binding as described above. Results are expressed as a percent
of the number of receptor sites present before hormone treatment.
Data are presented as means ± S.E.M. of at least three independent
experiments.
Table 1
Characterization of V2R mutants in transfected HEK cells
V2 Receptor AVP binding Adenylyl cyclase activity
Bmax (%WT) KD (nM) Vmax (%WT) EC50 (nM)
WT 100 5.0 ± 0.5 100 0.24 ± 0.06
K268A 6.0 ± 1.0 6.0 ± 0.5 9.0 ± 1.0 107.0 ± 14.5
K268D 22.0 ± 1.5 ND 48.0 ± 6.0 99.0 ± 13.0
K268E 15.0 ± 1.5 6.0 ± 0.5 28.0 ± 2.0 5.0 ± 1.0
K268R 99.0 ± 3.0 5.0 ± 0.5 72.0 ± 4.5 1.0 ± 0.1
D136K 3.0 ± 0.5 ND ND ND
E231K 123.0 ± 18 5.0 ± 1.0 59.0 ± 2.5 1.0 ± 0.2
D136K/K268D 4.0 ± 1.0 ND ND ND
E231K/K268E 154.0 ± 3.0 5.0 ± 0.5 4.0 ± 0.5 123.0 ± 14.0
Experiments were performed at least three times with transiently transfected HEK 293T cells.
Saturation-binding assays. 24 h after transfection, cells were plated in 24 well plates at a density of 400000 cells/well, the binding assays were
performed with intact cells 24 h later at 4 C using [3H] AVP in a previously described isotonic binding mixture [13]. After 2 h the binding mixture
was removed, the cells were washed twice with ice cold PBS containing Ca2+ and Mg2+, and lysed by adding 0.35 ml of 0.1 N NaOH. After 30 min
the lysed cells were transferred to a scintillation vial to measure radioactivity. Non-speciﬁc binding was determined in the presence of 5 lM
unlabeled AVP.
Adenylyl cyclase activity. Two days after transfection cells were rinsed with D-PBS plus Ca2+ and Mg2+, scraped oﬀ the dishes with a rubber
policeman and centrifuged. The supernatant was discarded and the cell pellets were suspended in approximately 10 volumes of ice-cold 27% (w/v)
sucrose, 1 mM EDTA, and 20 mM Na-HEPES, pH 7.8 (homogenization buﬀer) and homogenized in a Dounce homogenizer with 10 strokes of a
tight-ﬁtting pestle. Aliquots of the homogenate were used within 30 min to test for adenylyl cyclase activities. Homogenates were tested for AVP-
stimulated adenylyl cyclase activity using approximately 10 lg of protein for assay tube in the previously described incubation medium [13]. After
15 min incubations at 32 C the reactions were stopped and the [32P] cAMP was isolated by the method of Salomon et al. [24].
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HEK 293-T cells were transiently transfected with 9 lg of plasmid
DNA using the Lipofectamine 2000 transfection kit according to the
manufacturers instructions. After 8 h the cells were plated onto
100 mm dishes and analysed 16 h later. Cells were lysed by incuba-
tion in hypotonic buﬀer (50 mM Tris–HCl pH 7.5, 0.5 mM MgCl2,
150 mM potassium acetate, 1% Nonidet P-40, 1.5 mM dithiothreitol)
containing the COMPLETETM protease inhibitor cocktail. Lysis was
achieved by drawing the cells through needles of decreasing gauge
(20–25 G) ﬁtted to a 1 ml syringe. A post-nuclear supernatant was
prepared by centrifugation at 3000 rpm for 5 min. After protein con-
centration determination, supernatant aliquots containing 5 lg of
protein were incubated with an equal volume of 2· sample buﬀer
for 20 min. Samples were resolved by SDS PAGE. The V2R was
detected using a peptide puriﬁed rabbit polyclonal antibodies raised
against a peptide corresponding to the third intracellular loop
(Antibody 2) of the human V2R. Proteins were transferred to nitro-
cellulose using a Trans-Blot semi-dry blotter (BioRad). The nitro-
cellulose was blocked for 30 min in blotto (20 mM Tris–HCl pH
7.5, 150 mM NaCl, 5% powdered milk, 0.1% Tween 20) followed
by incubation with primary antibody (1:1000) overnight at 4 C.
The blot was washed three times for 10 min in blotto and incubated
with horseradish peroxidase-coupled secondary antibody for 1 h at
room temperature. After three more 10-min washes in blotto, the
proteins were visualized by ECL.2.11. Modeling protocol
To obtain a homology model for V2R, we sought to align its se-
quence with that of bovine rhodopsin as a structural template. Homo-
logs of V2R were gathered using a standard one-pass Blast search [1]
against the NCBI non-redundant database, resulting in 117 hits.
Homologs of bovine rhodopsin were gathered similarly, resulting in
153 hits. These two sets of homologous sequences were multiply
aligned separately using the ClustalW program [26]. Following this
the two multiple alignments were aligned as a pair, using the proﬁle
alignment option of ClustalW. From this proﬁle alignment a pairwise
alignment of V2R against rhodopsin was projected out.
The resulting pairwise alignment consisted of aligned blocks cover-
ing all of the secondary structure regions of bovine rhodopsin, with
gaps restricted to the connecting loops. An all atom homology model
was built for those residues of V2R that aligned with a residue of bo-
vine rhodopsin. The backbone coordinates were taken from the rho-
dopsin structure (Accession No. 1F88.pdb), along with sidechaincoordinates for conserved residues. Sidechain conformations for the
remaining residues were obtained by using the SCWRL program [9],
which employs a backbone-dependent rotamer library together with
a limited conformational search to avoid sidechain–backbone and side-
chain–sidechain clashes. The few clashes remaining in the structure
built from SCWRL were resolved manually, using the Swiss-PDB-
Viewer program [11].3. Results
The free amino groups of the lysine side chain are targets for
protein derivatization; for example lysine 268 has been studied
as a possible site of ubiquitination in the ligand occupied V2R
[18]. When this amino acid was substituted by alanine the
resulting mutant V2R was expressed at a much lower level
than the WT (5–7%) together with a signiﬁcantly reduced abil-
ity to stimulate adenylyl cyclase activity in the presence of
AVP (Table 1). No reduction of ligand-binding aﬃnity was de-
tected. The predicted location of K268 according to Kyte-
Doolittle analysis is the carboxyl terminal segment of the third
intracellular loop, but analysis of the crystal structure of bo-
vine rhodopsin shows the presence of two lysines, 245 and
248, within TM VI close to the cytoplasmic phase of the plas-
ma membrane [21]. The alignment of amino acids between the
human V2R, rat V1aR and bovine rhodopsin [1,26] shown in
Fig. 1A suggested that lysine 268 is probably at the boundary
between TM VI and the third intracellular loop, a location that
would explain the impact of the mutation on protein expres-
sion. Fig. 1A also shows that the V1a and V2 receptors contain
lysines in the carboxyl terminal segment of intracellular loop 3.
Thus, exchanging the loops between them preserved the posi-
tive charges in this region thereby masking their importance.
Our experiments revealed a role for lysine 268 on the folding
properties of the V2R as neutralization of this charged residue
altered V2R expression. Examination of the transmembrane
domains of many members of the rhodopsin subfamily of
Fig. 2. Evaluation of V2R abundance in whole cell lysate of
transfected cells. HEKT 293 cells were lysed 48 h after transfection
and a nuclei-free supernatant was made as described in the Methods
section. Aliquots containing 5 lg of extract of mock transfected cells
(C), cells expressing the wild type V2R (WT) or the E231KnK268E-
V2R(DM) were subjected to SDS–PAGE, transferred to a nylon
membrane and immunoblotted with an anti V2R antibody as
described in the Methods section. The arrow head point to the
precursor (non-glycosylated V2R).
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location, lysines in particular (see multiple sequence alignment
at GPCR data base www.cmbi.kun.nl/7tm/). This degree of
conservation suggested they could play a role in receptor struc-
ture and perhaps in receptor/G protein interaction.
As mentioned before, the K268A-V2R was poor at mediat-
ing AVP stimulation of adenylyl cyclase activity, eliciting a
maximal stimulation that was 10% of WT maximal activity
with an EC50 shifted more than 100-fold to the right (Table
1). As reported by Martin et al. [18], substitution of K268 by
arginine neither reduced protein expression nor modiﬁed
AVP binding, a common observation with amino acid substi-
tutions that do not dramatically alter the charge or side chain
length of the substituted amino acid. Nevertheless, a right shift
in the dose-response curve of AVP stimulation of adenylyl cy-
clase activity indicated that K268R-V2R was less eﬃcient at
activating Gs (Table 1) thereby suggesting lysine 268 was
needed for optimal signaling. These results conﬁrm the data re-
ported by Martin et al. [18].
Erlenbach and Wess identiﬁed the boundary between TM V
and the third intracellular loop of the V2R as important for Gs
coupling by progressive substitution of this region with seg-
ments of the V1a receptor 3i loop. They found glutamine
225 and glutamic acid 231 to be required for Gs coupling
and concluded that the amino terminal portion of intracellular
loop 3 was responsible for Gs activation [10].
The predicted three-dimensional structure of the V2R was
examined to evaluate the location of E231 and K268; this anal-
ysis indicated their proximity and suggested the possibility of
ionic interaction among them. Fig. 1B shows a model of the
tertiary structure of the V2R according to the Clustal align-
ment with rhodopsin. This model suggested the possibility of
ion pairing between lysine 268 and glutamic acid 231; aspartic
acid 136 of the DRH motif also emerged as a candidate. A
pairing between similar regions of TMs III and VI has been
shown for the b2-adrenergic receptor [2].
The single and double mutations were introduced at these
three amino acids to test the possibility of such pairing. Protein
expression was assessed by AVP binding, and the ability to
mediate the stimulation of adenylyl cyclase activity was exam-
ined for all mutant receptors with the results being summarized
in Table 1.
As previously observed with most GPCRs mutagenized in
the DR motifs, the D136K V2R was expressed poorly [2,19],
and no AVP-promoted stimulation of adenylyl cyclase activity
was detected in cell homogenates. The low level of expression
compromised the accurate determination of AVP-binding
aﬃnity. The D136K/K268D V2R had the same characteristics
of low expression and lack of stimulatory activity towards Gs,
thus neither expression nor activity was changed by the addi-
tional mutation.
Contrary to the eﬀect observed with themutation of aspartate
136, replacement of glutamic acid 231 by lysine enhanced recep-
tor expression by about 20% although it reduced receptor/Gs
signaling. The E231K V2R had unaltered hormone-binding
aﬃnity but AVP stimulation of adenylyl cyclase was right
shifted to anEC50 of 1.0 nM (Table 1). Themaximal stimulation
of adenylyl cyclase obtained with E231K-V2R was 60% of the
values achieved by the wild type, an impairment in coupling in
agreement with the data reported by Erlenbach and Wess [10].
Reciprocal substitution of lysine 268 by glutamic acid reduced
receptor expression without altering hormone-binding aﬃnityand created a receptor signiﬁcantly less eﬀective at stimulating
cAMP accumulation than the E231K-V2R. Both, maximal
stimulation of adenylyl cyclase activity (Vmax) and EC50 were
reduced, although not as much as observed with the alanine
and aspartic acid substitutions at the same site (see Table 1).
Introducing the double mutation E231K/K268E in the V2R
enhanced receptor expression thereby canceling out the nega-
tive impact of the K268E change. The V2R bearing the double
mutation (E231K/K268E) was consistently present in tran-
siently transfected cells at an abundance 50% higher than the
WTV2R asmeasured by AVP binding, suggesting that the dou-
ble change facilitated protein folding and/or traﬃc to the cell
surface. The levels of precursor and mature receptor present
in cells expressing the WT or the double-mutant V2R were as-
sessed by immunoblotting equal amounts of solubilized protein
as shown in Fig. 2. No signiﬁcant diﬀerence in the abundance of
the precursor form was detected indicating the double mutant
did not promote intracellular trapping.
The E231K/K268E V2R had the same ligand-binding aﬃn-
ity as the WT V2R and despite the fact that more mutant
receptor was made, the mutant protein had lost most its ability
to stimulate Gs/adenylyl cyclase (Table 1). Furthermore, the
stimulatory activity was remarkably lower than the values
measured for the individual mutations expressed at lower lev-
els. This result suggested that the double mutation at the ex-
tremes of the 3i loop generated an ion pairing that stabilized
protein folding and enhanced traﬃc to the cell surface,
although it impaired the ability of the receptor to activate Gs.
To verify the adenylyl cyclase data obtained with broken cell
homogenates, the ability of the double-mutant V2R to stimu-
late cAMP accumulation was compared to that of the wild
type V2R in intact cells. The stimulation of adenylyl cyclase
by the transfected V2 receptors was compared to the stimula-
tion obtained with 10 lM forskolin that directly stimulates
adenylyl cyclase activity. As shown in Fig. 3, the mutant
V2R increased cAMP accumulation only 40% over basal,
whereas the WT V2R promoted close to a 100-fold increase
in cAMP in all experiments. The higher sensitivity of the whole
cell assay made it possible to detect the residual activity of the
double-mutant V2R.
Fig. 5. Extent of ligand-induced phosphorylation of the WT and
E231K/K268E V2 receptors expressed in HEK 293T cells. Transfected
cells were labeled with 32P and receptor phosphorylation was stimu-
lated by exposing the cells to 100 nM AVP at 37 C for the times
indicated in the abscissa. The receptor was extracted, puriﬁed and
analyzed as previously described.
Fig. 3. Signaling activity of the WT and E231KnK268EV2R in intact
cells. The experiments were performed in 24 well plates with HEK
293T cells transiently transfected with plasmid encoding either the WT
or the mutant receptor; each point was determined in triplicate. One
day after transfection, the cells were distributed in 24 well plates at a
density of 400000 cells/well and labeled overnight with 2 lCi of [3H]
adenine. Accumulation of cAMP in the absence (basal) and presence
of 100 nM AVP or 10 lM forskolin was carried out as described in
Section 2. The data reported represent the average of two independent
experiments.
Fig. 4. Ligand-mediated internalization of the WT and E231K/K268E
V2 receptors. Experiments were performed as described in Section 2.
The fraction of cell surface receptors internalized during a 20 min
exposure to 100 nM AVP at 37 C and the lack of recycling after
removal of the ligand are shown. WT V2R, n; E231K/K268E V2R,¤.
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suggested that intramolecular movement might be impaired,
but upon ligand addition the protein was phosphorylated
and internalized to the same extent as the WT V2R as shown
in Fig. 4 for internalization and Fig. 5 for protein phosphory-
lation. Both receptor internalization and phosphorylation oc-
cur only in receptors occupied by agonist, antagonists do not
trigger these phenomena as they are restricted to the activated
form of GPCRs. Thus, this double mutation dissociates the
stimulatory activity of the occupied receptor towards Gs from
the conformational changes that lead to recognition by GPCR
kinases and the internalization adaptor proteins [14].4. Discussion
The data presented here revealed a role for lysine 268 in the
proper folding of the V2R protein. It is likely that this amino
acid assures optimal Gs activation since the similarly charged
arginine substitution failed to preserve full receptor function.
As shown in Fig. 1A, there is an arginine at position 271, close
to lysine 268, that could contribute a positively charged side
chain needed for signaling and structural ﬁdelity. Mutagenesis
of arginine 271 to histidine had no eﬀect on V2R expression,
ligand-binding aﬃnity or Gs activation (data not shown),
whereas substitution of lysine 268 by arginine impaired recep-
tor signaling through Gs as shown in Table 1. Our experiments
conﬁrmed the report of Erlenbach and Wess [10] describing the
importance of glutamate 231 on Gs activation, and indicated
that substitution of this amino acid by lysine enhanced protein
folding.
A three-dimensional model for the V2R was developed
based on its homology with bovine rhodopsin in an attempt
to predict the location of these charged amino acids. Fig. 1B
was obtained by assigning coordinates to the amino acids of
the V2R according to their position in a rhodopsin/V2R
alignment performed as described in the Methods section.
The simulation of the V2R structure predicted some proxim-
ity between lysine 268, glutamic acid 231 and aspartic acid
136 at the end of TM III suggesting they could be involved
in charge interaction. Without information about the orien-
tation of the side chains, this possibility is of course specu-
lative.
Introduction of the K268D mutation into the D136K V2R
did not have a compensatory eﬀect on receptor expression or
activity, whereas introduction of the E231K mutation into
the K268E V2R rescued the restrictions in protein synthesis
introduced by substituting lysine for glutamic acid and en-
hanced further the expression of E231K-V2R. This conse-
quence of the reciprocal change suggested the creation of ion
pairing between the stems of the 3i loop, an interaction that
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and transport to the cell membrane. The V2R containing
either one of these mutations retained a signiﬁcant fraction
of Gs stimulatory activity (Table 1), but combining them on
the same protein silenced the activity despite the increase in
protein abundance. It can be hypothesized that the double
mutation impairs the movement of the transmembrane regions
required to ‘‘open’’ Gs and promote GDP dissociation [6,7].
This putative pairing did not interfere with the conformational
changes caused by agonist binding that make the receptor a
good substrate for GPCR kinases [23] or with the ability of
arrestins and other adaptor proteins to interact with the recep-
tor and promote internalization [15]. The experiments reported
by Martin et al. had already shown that although lysine 268 is
not required for receptor internalization, it seems to enhance
the degradation of the internalized protein [18]. The extent
of phosphorylation and internalization of the double mutant
were identical as those of the wild type V2R.
The data presented lead to the conclusion that a reciprocal
change of the ionic charges at both ends of the third intracel-
lular loop abolishes the negative impact of modifying lysine
268 in terms of protein expression but impairs signiﬁcantly
the ability of the receptor to activate Gs. This loss of activity
does not interfere with receptor phosphorylation and internal-
ization triggered by agonist binding. The data suggest proxim-
ity of the two stems of the 3i loop, that is of transmembrane
domains V and VI, in the internal leaﬂet of the plasma mem-
brane; because mutagenesis of D136 reduced receptor expres-
sion so dramatically it was not possible to comment on the
probable location of the TM III. Changing these two charged
amino acids encompassing the third intracellular loop yielded
a structure more favorable for expression and/or traﬃc of
the V2R but reduced to a large degree the GEF activity stim-
ulated upon ligand binding [7].
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